With continuous efforts to maximize shareholder value,
will grow together with our shareholders.
Regulations on the Management of the Public Disclosure of Corporate Information of Yuyu Pharma Inc., Created by Yuyu Pharma, Sep. 1, 2009
Chapter 1: General Provisions
Article 1 (Purpose) The purpose of these regulations is to ensure that all corporate information of Yuyu Pharma is disclosed to the public accurately, completely, fairly, and in a timely manner in accordance with relevant laws and regulations. The Regulations also aim to determine necessary matters such as tasks and procedures related to the public disclosure of corporate information, and the management of the public disclosure of corporate information to prevent unfair trading practices by employees of Yuyu Pharma.
Article 2 (Scope of Application) Matters concerning the public disclosure and the management of the public disclosure of corporate information shall be governed by these regulations, except for those specified in laws, related regulations or the Articles of Incorporation.
Article 3 (Definition of Terms ) ① “The publicly disclosed information” means matters that may affect the investors' investment decision regarding the company's management and property, etc., and matters stipulated in relevant laws and regulations such as the Capital Market and Financial Investment Business Act (hereinafter referred to as the “Act”) and its Enforcement Decree (hereinafter referred to as the “Decree"), Regulations on Securities Issuance and Disclosure (hereinafter referred to as “the Regulations on Issuance and Disclosure”) of the Financial Services Commission (FSC) , and the Securities Market Disclosure Regulations (hereinafter referred to as the “Disclosure Regulations”) of the Korea Exchange (KRX).
②“Publicly disclosed documentation” means reports, declarations, notifications and documents (including electronic documents) submitted for disclosure and documents attached thereto.